Home
>
National Drug Code (NDC)
>
Clarinex
Clarinex - 0085-1264-02 - (Desloratadine)
Drug Information of Clarinex
| Product NDC: | 0085-1264 |
| Proprietary Name: | Clarinex |
| Non Proprietary Name: | Desloratadine |
| Active Ingredient(s): | 5 mg/1 & nbsp; Desloratadine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clarinex
| Product NDC: | 0085-1264 |
| Labeler Name: | Schering Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021165 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101222 |
Package Information of Clarinex
| Package NDC: | 0085-1264-02 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (0085-1264-02) |
NDC Information of Clarinex
| NDC Code | 0085-1264-02 |
| Proprietary Name | Clarinex |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (0085-1264-02) |
| Product NDC | 0085-1264 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Desloratadine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20101222 |
| Marketing Category Name | NDA |
| Labeler Name | Schering Corporation |
| Substance Name | DESLORATADINE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
